ViewPoint Therapeutics is an early stage biotechnology company focused on the development of small molecule treatments for protein misfolding diseases, including cataracts and presbyopia.
Total raised: $39M
Investors 4
| Date | Name | Website |
| - | The Rise F... | therisefun... |
| - | Asset Mana... | assetman.c... |
| - | MBC BioLab... | mbcbiolabs... |
| - | Lagunita B... | lagunitabi... |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 05.03.2018 | Series B | $35M | - |
| 05.05.2016 | Series A | $4M | - |
Mentions in press and media 5
| Date | Title | Description | Source |
| 12.03.2018 | ViewPoint Therapeutics Raises $35M in Series B | SAN FRANCISCO, CA, Privately-held biotechnology company pioneering the development of crystallin s... | vcnewsdail... |
| 12.03.2018 | Term Sheet — Monday, March 12 | SO LONG, VC Good morning, Term Sheet readers. Paid Content What you need to know about growing cyb... | fortune.co... |
| 05.03.2018 | ViewPoint Therapeutics Raises $35 Million in Series B Financ... | - | mbcbiolabs... |
| 06.05.2016 | ViewPoint Therapeutics Closes $4M Series A Financing | ViewPoint Therapeutics, Inc., a San Francisco, CA-based biotechnology company pioneering the develop... | finsmes.co... |
| 05.05.2016 | ViewPoint Therapeutics Raises $4 Million in Series A Financi... | - | mbcbiolabs... |